Cite

HARVARD Citation

    Zuraw, B. et al. (n.d.). Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate. Allergy. 70 (10), pp. 1319-1328. [Online]. 
  
Back to record